Schedule 13G ownership disclosure

Immuneering Corp

Security class unavailable · CUSIP: 45254E107

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,378,100
Percent of class
11.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-24-000761
Form type
SC 13G/A
Filer
Immuneering Corp
CIK
CIK 1790340
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub